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Neurobiology of Disease
Local BDNF Delivery to the Injured Cervical Spinal Cord
using an Engineered Hydrogel Enhances Diaphragmatic
Respiratory Function
XBiswarup Ghosh,1* ZhichengWang,2* Jia Nong,2MarkW. Urban,1 Zhiling Zhang,2 Victoria A. Trovillion,1
Megan C. Wright,3 XYinghui Zhong,2 and Angelo C. Lepore1
1Department of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Sidney Kimmel Medical College at Thomas Jefferson University,
Philadelphia, Pennsylvania 19107, 2School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, Pennsylvania 19104,
and 3Department of Biology, Arcadia University, Glenside, Pennsylvania 19038
We developed an innovative biomaterial-based approach to repair the critical neural circuitry that controls diaphragm activation by
locally delivering brain-derived neurotrophic factor (BDNF) to injured cervical spinal cord. BDNF can be used to restore respiratory
function via a number of potential repairmechanisms; however, widespreadBDNFbiodistribution resulting fromdeliverymethods such
as systemic injection or lumbar puncture can lead to inefficient drug delivery and adverse side effects. As a viable alternative, we
developed a novel hydrogel-based system loaded with polysaccharide-BDNF particles self-assembled by electrostatic interactions that
can be safely implanted in the intrathecal space for achieving local BDNF delivery with controlled dosing and duration. Implantation of
BDNF hydrogel after C4/C5 contusion-type spinal cord injury (SCI) in female rats robustly preserved diaphragm function, as assessed by
in vivo recordings of compound muscle action potential and electromyography amplitudes. However, BDNF hydrogel did not decrease
lesion size or degeneration of cervicalmotor neuron soma, suggesting that its therapeuticmechanism of action was not neuroprotection
within spinal cord. Interestingly, BDNF hydrogel significantly preserved diaphragm innervation by phrenicmotor neurons (PhMNs), as
assessed bydetailed neuromuscular junctionmorphological analysis and retrogradePhMN labeling fromdiaphragmusing cholera toxin
B. Furthermore, BDNFhydrogel enhanced the serotonergic axon innervationofPhMNs that plays an important role inmodulatingPhMN
excitability. Our findings demonstrate that local BDNF hydrogel delivery is a robustly effective and safe strategy to restore diaphragm
function after SCI. In addition, we demonstrate novel therapeutic mechanisms by which BDNF can repair respiratory neural circuitry.
Key words: biomaterial; contusion; diaphragm; phrenic motor neuron; respiratory; spinal cord injury
Introduction
Respiratory dysfunction is a major problem following cervical
spinal cord injury
Pulmonary compromise is a leading cause of mortality and mor-
bidity after SCI, both acutely and at chronic stages (Shanmuga-
nathan et al., 2008). There is decreased life expectancy for
ventilator-dependent patients, often due to respiratory infec-
tions. Limited spontaneous respiratory recovery can occur after
spinal cord injury (SCI); however, this response is often insuffi-
cient to allow patients to regain significant breathing function or
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Significance Statement
Respiratory compromise is a leading cause of morbidity and mortality following traumatic spinal cord injury (SCI). We used an
innovative biomaterial-based drug delivery system in the form of a hydrogel that can be safely injected into the intrathecal space
for achieving local delivery of brain-derived neurotrophic factor (BDNF)with controlled dosing and duration, while avoiding side
effects associated with other delivery methods. In a clinically relevant rat model of cervical contusion-type SCI, BDNF hydrogel
robustly and persistently improved diaphragmatic respiratory function by enhancing phrenicmotor neuron (PhMN) innervation
of the diaphragm neuromuscular junction and by increasing serotonergic innervation of PhMNs in ventral horn of the cervical
spinal cord. These exciting findings demonstrate that local BDNF hydrogel delivery is a safe and robustly effective strategy to
maintain respiratory function after cervical SCI.
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to perform other important pulmonary tasks such as coughing
(which can result in respiratory infection; Warren and Alilain,
2014). Importantly, cervical SCI represents greater than half of all
human cases, in addition to often resulting in the most severe
physical and psychological debilitation (Lane et al., 2008). Cervi-
cal trauma disrupts the critical neural circuitry that controls a
number of respiratory muscles, in particular the diaphragm
(Warren et al., 2014).
Diaphragm dysfunction plays a central role in respiratory
compromise after cervical SCI
Compromised inspiratory breathing occurs in a significant per-
centage of SCI patients due to paralysis of the major inspiratory
muscle, the diaphragm (but likely also via effects on other mus-
cles; Strakowski et al., 2007). The diaphragm is innervated by
phrenic motor neurons (PhMNs) located at cervical levels 3–5
(Lane et al., 2009). PhMNoutput is driven by descending premo-
tor bulbospinal neurons in a brainstem nucleus called the rostral
ventral respiratory group (rVRG; Zimmer et al., 2007). Cervical
SCI results in diaphragmatic respiratory compromise due to (1)
PhMN loss and consequent denervation at the diaphragm neu-
romuscular junction (NMJ), and (2) injury to descending bul-
bospinal respiratory axons and consequent silencing of spared
PhMNs.
Brain-derived neurotrophic factor hydrogel delivered locally
to cervical SCI is a clinically applicable approach to repair
respiratory neural circuitry
We chose to deliver brain-derived neurotrophic factor (BDNF)
as it can potentially repair rVRG–PhMN–diaphragm circuity af-
ter cervical contusion via a number of therapeutic mechanisms,
including the following: (1) reducing secondary degeneration of
this neural circuit that occurs following initial trauma (Novikova
et al., 2000); (2) promoting regrowth of injured rVRG axons
and/or sprouting of spared rVRG fibers (Weishaupt et al., 2012);
(3) acting as a guidance molecule to direct rVRG axon reinner-
vation of their appropriate PhMN targets (Weishaupt et al.,
2012); (4) modulating PhMN properties such as dendritic mor-
phology, intrinsic excitability, glutamate receptor expression
profile (Gill et al., 2016), and activation in response to excitatory
synaptic input (Dale-Nagle et al., 2010); (5) enhancing synaptic
transmission at the diaphragm NMJ (Mantilla et al., 2004; Gran-
see et al., 2013); and (6) maintaining diaphragm NMJ innerva-
tion and/or stimulating morphological changes at the NMJ such
as terminal sprouting of phrenic motor axons and reinnervation
of denervated endplates (Pitts et al., 2006).We have attempted to
harness the multifaceted therapeutic potential of BDNF to pro-
mote repair of the critical neural circuitry controlling diaphragm
function. In this study, we have specifically assessed the ability of
BDNF tomodulate (1) diaphragm innervation by phrenic motor
axons peripherally at the NMJ and (2) PhMN innervation by
descending serotonergic input centrally within the ventral horn,
given that they are both critical to diaphragm activation and that
the effects of BDNF on these mechanisms have not been assessed
in the context of respiratory circuitry after SCI. Importantly, a
number of neuronal components of the rVRG–PhMN–dia-
phragm circuit express the tropomyosin-related kinase receptor
subtype B (TrkB) receptor, including PhMNs (Mantilla et al.,
2013, 2014a) and serotonergic raphe neurons (Goswami et al.,
2010). We have also found that rVRG neurons express TrkB (B.
Charsar and A. Lepore unpublished observations), suggesting
that BDNFhydrogel could also act upon these neurons to induce,
for example, plasticity within the cervical spinal cord such as the
regrowth of injured rVRG axons and/or sprouting of spared
rVRG fibers to increase descending bulbospinal input to the
PhMN pool.
Hydrogel-based system allows for safe delivery of BDNF to
cervical SCI
Both intrathecal injection of BDNF solution (Mantilla et al.,
2013; Hernandez-Torres et al., 2017) and intraspinal transplan-
tation of BDNF-expressing mesenchymal stem cells (Gransee et
al., 2015) partially improve diaphragm muscle activity in rodent
models of cervical SCI.Unlike the targeted local delivery achieved
with our system, clinically used lumbar intrathecal injection can
result in more widespread distribution, and strategies such as
viral delivery and cell transplantation may result in persistent
expression, which potentially reduces its efficacy. Previous stud-
ies have also reported that persistent, anatomically widespread
distribution of high levels of BDNF in the spinal cord can induce
unwanted side effects such as neuropathic pain, hyperreflexia,
and abnormal limb motor function that prevent its therapeutic
use (Boyce and Mendell, 2014). Furthermore, clinical trials for
nervous system diseases using systemic delivery of various neu-
rotrophic factors have been associated with both side effects and
lack of therapeutic efficacy (Miller et al., 1996). To address these
important issues, we have developed a biocompatible drug deliv-
ery system in the form of a hydrogel loaded with polysaccharide-
BDNF particles self-assembled by electrostatic interactions. We
have used this biomaterial-based platform to locally deliver
BDNF to the injured cervical spinal cord with controlled dura-
tion to effectively repair rVRG–PhMN–diaphragm circuitry and
consequently rescue diaphragmatic respiratory function with
minimized side effects.
Materials andMethods
Animals. Female Sprague Dawley rats weighing 250–300 g were pur-
chased from Taconic Farms. All animals were housed in a humidity-,
temperature-, and light-controlled animal facility with ad libitum access
to water and food. All experimental procedures were performed in com-
pliance with protocols approved by the Thomas Jefferson University
Institutional Animal Care and Use Committee (IACUC) and the Drexel
University IACUC, as well as in accordance with the Society for Neuro-
science “Policies on the Use of Animals and Humans in Neuroscience
Research.”
Unilateral cervical contusion model. We used only female rats as we
extensively optimized and comprehensively characterized the unilateral
cervical contusion SCI model both functionally and histologically in fe-
male rats in our previouswork (Nicaise et al., 2012, 2013). This contusion
paradigm results in robust secondary PhMN degeneration, interruption
of descending axonal populations that innervate the PhMN pool, and
persistent diaphragm dysfunction. Briefly, cervical contusion was per-
formed on the right side of spinal cord. Rats were deeply anesthetized
with an intraperitoneal injection of a cocktail of ketamine (100 mg/kg),
xylazine (5mg/kg), and acepromazine (2mg/kg). The cervical dorsal skin
and underlying muscles were incised. The paravertebral muscles overly-
ing C4–C5 were removed. At level C4/C5, rats were then subjected to a
contusion using the InfiniteHorizon Spinal Impactor (Precision Systems
and Instrumentation) using a 1.5 mm tip at a force of 395 kdyn.
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Formulation and administration of hydrogels. Dextran sulfate (DS;
Sigma-Aldrich) and BDNF (PeproTech) were dissolved in deionized wa-
ter at final concentrations of 4 and 0.8 mg/ml, respectively. The 4 mg/ml
chitosan (CH) solution was prepared in 0.6% (v/v) acetic acid. Ten mi-
croliters of DS and BDNF solution was then mixed with 4 mg/ml CH in
equal volume to form self-assembled DS–CH–BDNF complexes (parti-
cles). After centrifugation at 10,000 rpm for 10 min to remove superna-
tant, the complexes were loaded in 20l of 1.5% (w/v) agarose hydrogel.
Immediately after the contusion SCI, 20 l of agarose hydrogel loaded
with DS–CH–BDNF complexes was administered into the intrathecal
space at the injury site. Another 100 l of blank agarose hydrogel was
applied epidurally to protect the injury site.
Characterization of BDNF release. To measure BDNF release, rhoda-
mine was conjugated to BDNF following a protocol provided by the
Pierce Rhodamine Protein Labeling Kit (Thermo Fisher Scientific). A
mixture of equal amounts of rhodamine-BDNF and BDNF was used to
fabricate the drug delivery system following the procedures described
above. Agarose hydrogel loaded with DS–CH–BDNF particles was incu-
bated in HBSS, pH 7.4, at 37°C for quantification of BDNF release. The
release media were changed every 24 h. The amount of BDNF released
every 24 h was quantified by measuring at an excitation wavelength of
552 nm and an emission wavelength of 575 nm.
Bioactivity of released BDNF. Rat cortical neurons were used to assess
the bioactivity of released BDNF. The cortices were isolated from embry-
onic day 17 rat embryos in accordance with protocols approved by the
Drexel University IACUC. Dissociated cortical cells were seeded at a
density of 120,000 cells/cm2 and maintained in Neurobasal medium
supplementedwith 2%B27 supplement and 2mM L-glutamine. After 7 d,
B27 supplement in the culture medium was replaced by B27 minus an-
tioxidants (AOs) to remove the neuroprotective AOs from the culture
medium. The neurons were then treated with 100M hydrogen peroxide
(H2O2); 100MH2O2 supplemented with equal amounts of fresh BDNF
and rhodamine-BDNF at a total concentration of 30 ng/ml, with or
without 120 ng/ml anti-BDNF blocking antibody (PeproTech); 100 M
H2O2 supplemented with BDNF released during a 24 h period on day 17
(containing a mixture of BDNF and rhodamine-BDNF, which was di-
luted to 30 ng/ml), with or without 120 ng/ml anti-BDNF blocking an-
tibody; or 100 M H2O2 supplemented with release medium from
hydrogel loaded with DS-CH particles without BDNF. Untreated neu-
rons were used as a negative control. After 6 h, cell viability was quanti-
fied using the alamarBlue cell viability assay. The cells were then stained
with 2 M Calcein AM (live staining) and imaged with an inverted fluo-
rescence microscope (Leica).
Diaphragm compoundmuscle action potential measurements.Rats were
anesthetized with isoflurane at a concentration of 2.0–2.5%. Phrenic
nerve conduction studieswere performedwith single stimulation (0.5ms
duration; 6 mV amplitude) at the neck (either ipsilateral or contralateral
to the contusion site) close to the passage of the phrenic nerve (Lepore et
al., 2010; Li et al., 2014), and a ground needle electrode was inserted into
the tail. A reference electrode was placed in the right abdominal region
subcutaneously. Reproducibility was ensured by recording 10–20 times
with a 5 s interval between stimulations. Recording was obtained via a
surface strip along the costal margin of the diaphragm, and compound
muscle action potential (CMAP) amplitude was measured from baseline
to peak. Recordings weremade using an PowerLab 8/30 Stimulator and a
BioAmp Amplifier (ADInstruments), followed by computer-assisted
data analysis (Scope 3.5.6, ADInstruments; RRID:SCR_001620). CMAPs
were measured three times for each animal at 1 week intervals following
SCI/treatment.
EMG recordings. Animals were anesthetized with isoflurane at a concen-
tration of 3.0%. Once deeply anesthetized, a laparotomy was performed to
expose the hemidiaphragm ipsilateral or contralateral to the contusion. Bi-
polar electrodes spacedby3mmwere inserted into specific subregionsof the
hemidiaphragm (i.e., dorsal, medial, or ventral subregions; Li et al., 2015).
Recordings were averaged over a 2 min time frame for each animal, and
peak amplitude, burst duration, and frequency were measured. Using
LabChart 7 software (ADInstruments; RRID:SCR_001620), the EMG
signal was amplified and filtered through a bandpass filter (50–3000Hz).
EMG recordings were conducted once per animal immediately before
the animal was killed.
Retrograde labeling of PhMNs in cervical spinal cord. Two weeks before
the animal was killed, cholera toxin B subunit (CTB) conjugated to Alexa
Fluor 647 (Life Technologies) was injected unilaterally into the intra-
pleural space of the ipsilateral hemidiaphragm under anesthesia (Nicaise
et al., 2012; Li et al., 2014). This procedure was conducted to specifically
label PhMN soma/dendrites in the ventral horn of the cervical spinal
cord. In brief, following laparotomy, 15 l of CTB (0.2% solution in
distilled water) was intrapleurally delivered transdiaphragmatically (3
injections of 5 l each) using a 20 l Hamilton syringe. Abdominal
muscles and skin were then sutured separately.
Perfusion and spinal cord dissection.Animals were killed with amixture
of ketamine (300 mg/kg), xylazine (15 mg/kg), and acepromazine (6
mg/kg). After the hemidiaphragm was dissected, the animals were per-
fused using 0.9% saline solution, followed by 4% paraformaldehyde so-
lution. Spinal cord and brain were then removed and postfixed in a 4%
paraformaldehyde solution overnight at 4°C. After cryoprotection in
30% sucrose for 3 d, cervical spinal cords were embedded in tissue-
freezingmedium and then frozen in dry ice. Spinal cord sections were cut
(in both transverse and sagittal orientations) at a thickness of 20 m.
Assessment of lesion volume and ventral hornmotor neurons.Transverse
spinal cord sections 160mapart were stainedwith cresyl violet forNissl
bodies and Eriochrome cyanine for myelin. The lesion area on each
section was quantified using ImageJ software (RRID:SCR_003070) to
calculate the total lesion volume. Motor neurons were outlined in Nissl
myelin-stained sections in the cervical spinal cord ventral horn. Motor
neuron cell bodies with a clearly identifiable nucleolus and a soma of
200 m2 were counted in a blinded manner (Lepore et al., 2011).
PhMNs in the C3–C5 ventral horn specifically labeled with CTB were
also counted in transverse sections spaced 160 m apart in a blinded
manner.
Neuromuscular junction staining. Fresh hemidiaphragm was dissected
before perfusion for whole-mount immunohistochemistry (Wright et
al., 2007; Li et al., 2014). Briefly, muscle was stretched, pinned down to
Sylgard medium (Thermo Fisher Scientific), and extensively cleaned to
remove any connective tissue to allow for antibody penetration. Motor
axons and their terminals were labeled with primary antibodies SMI-
312R (Covance; RRID:AB_2314906) and SV2-s (Developmental Studies
Hybridoma Bank at the University of Iowa, Iowa City, IA; RRID:
AB_2315387), respectively, and both antibodies were detectedwith FITC
anti-mouse IgG secondary (Jackson ImmunoResearch). Postsynaptic
acetylcholine receptors were labeled with rhodamine-conjugated
-bungarotoxin (Life Technologies). Diaphragms were then mounted
with VECTASHIELD mounting medium (Vector Laboratories), cover-
slipped, and stored at 20°C. Labeled muscles were then analyzed for
total numbers of intact, completely denervated and partially denervated
NMJs. Muscle was imaged on a FluoView FV1000 Confocal Microscope
(Olympus; RRID:SCR_014215). We conducted NMJ staining only in
ipsilateral hemidiaphragm because in our previous study we did not
observe significant denervation or sprouting in contralateral hemidia-
phragm after unilateral cervical contusion SCI (Nicaise et al., 2012).
Immunohistochemistry. Frozen transverse spinal cord sections were air
dried, washed, and finally permeabilized with 0.4% Triton X-100 in PBS
for 5min at room temperature. For immunohistochemistry of 5-HT and
the presynapticmarker Synaptophysin, sampleswere incubated in block-
ing solution (PBS containing 5% normal goat serum, 1% Triton X-100,
and 0.05%Tween 20) for 2 h at room temperature. Sections were labeled
overnight at 4°C with mouse synaptophysin antibody (1:250; Abcam;
RRID:AB_2198854), and rabbit 5-HT antibody (1:15,000; Immunostar;
RRID:AB_572263) in blocking solution. Sectionswere thenwashed three
times with PBS (5 min/wash) and incubated with Alexa Fluor 405 goat-
anti-mouse (1:200; Abcam) and Alexa Fluor 488 goat-anti-rabbit (1:200;
Jackson ImmunoResearch) in blocking solution for 2 h at room temper-
ature. After washing three times with PBS (5 min/wash), sections were
coverslipped. Images were acquired with a Zeiss Imager M2 Upright
Microscope or on a FluoView FV1000 Confocal Microscope (Olympus),
and MetaMorph software (Molecular Devices; RRID:SCR_002368) was
used for quantification.
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Quantification of 5-HT immunohistochemistry. For quantitative analy-
sis of 5-HT immunostaining (see Fig. 9), we used the same image acqui-
sition parameters for all samples, including excitation light intensity,
camera settings, and exposure time. In transverse sections, we created
concentric circles of increasing radii of 50mmeasured from the CTB
PhMN location. We quantified the number of 5-HT axon profiles, total
5-HT axonal length, and integrated intensity of 5-HT immunolabeling at
each distance (0–50, 50–100, and 100–150 m). For quantification of
putative synaptic contacts between 5-HT/synaptophysin terminals
andCTB-labeled PhMNs, we considered those contacts within 2.5mof
the surface of the CTB PhMN in single-z confocal images, based on
previous work (Kinkead et al., 1998; Issa et al., 2010).
Experimental design and statistical analysis. In the Results section, we
provide details of group means, SEM, statistical tests used, and results of
statistical analyses (including the exact p value) for each experiment.
We gave careful thought to minimizing animal numbers. To conduct
an a priori power analysis (with SigmaPlot 12) for studies involving in
vivo diaphragm functional analysis, spinal cord histology, spinal cord
immunohistochemistry, andwhole-mountmuscle labeling, we used pre-
viously obtained values (i.e., EMG and CMAP recordings, lesion size
analysis, motor neuron counts, CTB labeling, NMJ morphology assess-
ment, and 5-HT axon quantification) from our laboratories for rats sub-
jected to this same cervical contusionmodel to generate an estimate of SD.
We conducted all surgical procedures, as well as all quantitative histo-
logical and functional analyses, in a blinded fashion. The surgeon con-
ducting the contusion and hydrogel injection were blinded to the
experimental group identity of a given animal throughout the study. In
addition, the experimenters conducting EMG and CMAP recordings did
not know the group identity of the animals being assessed. Furthermore,
experimenters were blinded to the sample identity during subsequent
quantitative analysis of these functional assays, as well as while conduct-
ing all histological analyses following the killing of an animal. Before
starting a study, rats were randomly assigned to experimental groups,
and the different hydrogels used within a given experiment were ran-
domly distributed across these rats. In order for an animal to be included
in functional and histological quantification, we verified using lesion
analysis that the contusion injury was properly located at the appropriate
spinal cord level and that the injury was targeted to just the right side of
the spinal cord.
Results were expressed as the mean  SEM. An unpaired t test was
used to assess statistical significance between two groups.With respect to
multiple comparisons involving three or more groups, statistical signifi-
cance was assessed by ANOVA. Statistics were computed with GraphPad
Prism 5 (GraphPad Software). A p value0.05 was considered as statis-
tically significant.
Results
Bioactive BDNF was released from
agarose hydrogel loaded with DS–CH–
BDNF complexes for>17 d
In this study, we found that negatively
charged DS could form self-assembled
complexes (particles) with positively
charged CH and BDNF possibly through
electrostatic interaction. We embedded
these particles in agarose hydrogel so that
they can remain localized at the injury site
in vivo. Relatively high amounts of BDNF
were released from BDNF-loaded hydro-
gel in vitro in the first 2 d, followed by
low-dose release (364.2–29.5 ng/d) for
15 d (Fig. 1 ). We further investigated
whether this novel drug delivery system is
capable of maintaining the bioactivity of
encapsulated BDNF. H2O2-induced mas-
sive loss of cortical neurons in vitro
(18.29  0.80% viability vs 100  2.23%
for untreated control; Fig. 2A,B), whereas
fresh BDNF (38.94 1.38%; Fig. 2D) or BDNF released from the
hydrogel on day 17 (38.36 1.13%; Fig. 2E; diluted to the same
concentration as fresh BDNF) improved neuron survival (F(6,114)
 427.1, Tukey’s post-test; H2O2 vs fresh BDNF, p  0.0001;
H2O2 vs released BDNF, p  0.0001; released without BDNF vs
fresh BDNF, p  0.0001; released without BDNF vs released
BDNF, p 0.0001; ANOVA; n 3/group). Anti-BDNF antibody
completely blocked the neuroprotective effect of both fresh
(18.76 1.13%; Fig. 2F) and hydrogel-released (17.53 0.47%;
Fig. 2G) BDNF (F(6,114) 427.1, Tukey’s post-test; fresh BDNF vs
fresh BDNF Ab, p 0.0001; released BDNF vs released BDNF
 Ab, p 0.0001; ANOVA; n 3/group), suggesting both that
the neuroprotective effect was from BDNF and that this drug
delivery system itself was not neuroprotective. Quantitative cell
viability assessment confirmed that both fresh and hydrogel-
released BDNF significantly inhibited H2O2-induced neurotox-
icity (Fig. 2H). Moreover, there was no significant difference in
cell viability between neuronal cultures treated with fresh and
hydrogel-released BDNF, suggesting that the polysaccharide-
based BDNF delivery systemmaintained the activity of BDNF for
at least 17 d. In addition, release medium from agarose hydrogel
loaded with DS-CH particles without BDNF showed no neuro-
protective or neurotoxic effect (17.53  0.47%; Fig. 2C); this
result is consistent with that of the anti-BDNF antibody blocking
test and confirms the safety of this drug delivery system.
BDNF hydrogel implantation significantly improved
diaphragm function following cervical contusion SCI
In a rat model of unilateral C4/C5 contusion SCI, we subdurally
implanted BDNF hydrogel or blank hydrogel control at the level
of the contusion immediately postinjury. We tested the in vivo
effects of hydrogel implantation on diaphragmatic respiratory
function by quantifiably measuring both inspiratory EMGs and
evoked CMAPs in anesthetized rats.
We assessed EMG burst amplitude as a measure of rhythmic
diaphragm activation under normal eupnic breathing condi-
tions.We conducted intradiaphragm EMG recordings separately
from ventral, medial, and dorsal subregions of the hemidia-
phragm ipsilateral to the contusion. We and others have previ-
ously shown that each diaphragm subregion is innervated by
PhMNs whose cell bodies are located at different rostral–caudal
Figure 1. BDNFwas released fromhydrogel loadedwith DS–CH–BDNF complexes for17 d. Inset depicts release profile from
3 to 17 d. n 3/group.
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portions of the C3-C5 spinal cord (Li et al., 2015). In contusion
animals implanted with blank hydrogel, we observed the largest
loss of EMG amplitude in the dorsal subregion of the muscle
(1.7 0.34 vs 8.16 0.83mV/s for the intact contralateral hemi-
diaphragm; Fig. 3A,C), which is primarily innervated by the
most caudal portion of the PhMN pool. Importantly, we per-
formed the contusion at C4/C5, demonstrating that the portion
of the PhMN pool most severely affected by the injury matched
the subregion of the hemidiaphragm with the lowest EMG am-
plitudes. EMG amplitudes in the ventral and medial subregions
of the muscle were not as severely reduced compared with EMG
amplitudes obtained from these same subregions in the control
uninjured condition (Fig. 3C), particularly in the ventral subre-
gion, which is primarily innervated by the most rostrally located
PhMNs (i.e., on the opposite end from the contusion). In addi-
tion, BDNF showed no effect on EMGamplitudes at these ventral
(blank gel, 4.89  0.70 mV/s; BDNF, 4.59  0.34 mV/s) and
medial (blank gel, 2.96 1.10 mV/s; BDNF, 3.04 0.13 mV/s)
hemidiaphragm locations compared with blank hydrogel control
(F(6,21)  10.47; Tukey’s post-test; ventral: blank vs BDNF, p 
0.9; medial: blank vs BDNF, p  0.9; contralateral vs ventral/
blank, p  0.06; contralateral vs ventral/BDNF, p  0.06; con-
tralateral vs medial/blank, p  0.0004; contralateral vs medial/
BDNF, p  0.0015; ANOVA; n  4 rats/group; Fig. 3C).
Compared with blank hydrogel-implanted animals (Fig. 3A),
BDNF hydrogel resulted in significantly greater diaphragm EMG
amplitudes in the dorsal subregion (blank gel, 1.4  0.42 mV/s;
BDNF, 5.02  0.41 mV/s) at 5 weeks post-SCI (F(6,21)  10.47;
Tukey’s post-test; dorsal: blank vs BDNF, p 0.04; contralateral
vs dorsal/blank, p  0.0001; contralateral vs dorsal/BDNF, p 
0.053; ANOVA;n 4 rats/group; Fig. 3B,C).Nodifferenceswere
noted in burst frequency (dorsal subregion: blank gel, 34.72 
2.39 bursts/min; BDNF, 32  6.81 bursts/min; F(5,14)  1.05;
Tukey’s post-test; ventral: blank vs BDNF, p 0.9; medial: blank
vs BDNF, p 0.92; dorsal: blank vs BDNF, p 0.9; ANOVA; n
4 rats/group; Fig. 3D) or burst duration (dorsal subregion: blank
gel, 0.50  0.06 s; BDNF, 0.61  0.45 s; F(5,14)  1.87, Tukey’s
post-test; ventral: blank vs BDNF, p  0.59; medial: blank vs
BDNF, p 0.90; dorsal: blank vs BDNF, p 0.62; ANOVA; n
4 rats/group; Fig. 3E) between blank hydrogel and BDNF hydro-
gel groups at any diaphragm subregion, and these burst fre-
quency and duration values in hydrogel-implanted contusion
rats were similar to those in uninjured control animals that we
assessed in previous work (Li et al., 2015).
We also conducted CMAP recordings from the ipsilateral
hemidiaphragm in response to supramaximal phrenic nerve
stimulation. Unlike spontaneous EMG recordings, this tech-
nique allowed us to selectively quantify functional innervation of
the diaphragm by PhMNs independent of the contribution of the
descending bulbospinal drive. Unlike with EMGs in which we
insert small needle electrodes into specific subregions of themus-
cle, we recorded CMAP amplitudes from the entire hemidia-
phragm simultaneously using a surface electrode. We obtained
CMAP recordings separately from both the ipsilateral and con-
tralateral hemidiaphragm (Fig. 4A). Starting at 2 weeks postcon-
tusion and continuing until the last recording time point at 3
weeks postcontusion, the BDNF hydrogel group (week 1, 5.70
0.28 mV; week 2, 6.33  0.48 mV; week 3, 6.56  0.31 mV)
showed increased peak CMAP amplitude in the ipsilateral hemi-
diaphragm compared with the blank hydrogel group (week 1,
Figure 2. Released BDNFmaintained bioactivity throughout the duration of release. A–G, Representative images showing themorphology of cultured cortical neurons stainedwith calcein AM.
Scale bar, 100m. H, Viability under different treatments. We expressed results as the mean SEM. ****p 0.0001.
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4.37 0.42mV;week 2, 3.92 0.33mV;week 3, 3.58 0.27mV;
F(7,24)  11.64, Tukey’s post-test; blank vs BDNF: week 1, p 
0.15; week 2, p 0.001; week 3, p 0.0001, ANOVA; n 4 rats/
group; Fig. 4B). Furthermore, CMAP amplitudes obtained from the
ipsilateral hemidiaphragm of blank hydrogel animals were signifi-
cantly reduced at all time points comparedwith the intact contralat-
eral hemidiaphragm of the same animals (blank gel, 6.13  0.27
mV),while BDNFhydrogel rescuedCMAPamplitudes in ipsilateral
hemidiaphragm compared with the within-animal intact contralat-
eral hemidiaphragm (BDNF, 5.82 0.3 mV; Fig. 4B).
Collectively, these electrophysiological findings using two
powerful in vivo assessments of muscle activation demonstrate
that implantation of BDNF hydrogel locally at the site of cervical
contusion SCI robustly and persistently preserved diaphragm
function.
BDNF hydrogel did not decrease lesion size, lesion volume, or
cervical motor neuron cell body degeneration following
cervical contusion SCI
To determine whether BDNF hydrogel improved diaphragmatic
respiratory function after C4/C5 contusion via a central neuro-
protective effect within the cervical spinal cord, we quantified
both lesion size and sparing of ventral horn motor neurons. In
cresyl violet-stained transverse sections of the cervical spinal cord
Figure 3. BDNF hydrogel implantation significantly improved diaphragm function following cervical contusion SCI. At 5 weeks after contusion/hydrogel implantation, we obtained EMG
recordings from ipsilateral hemidiaphragm. A, B, Representative raw (top) and integrated (bottom) EMG traces for the blank hydrogel (A) and BDNF hydrogel (B) groups. C–E, We quantified
integrated EMG amplitude (C), burst frequency (D), and burst duration (E). We expressed results as the mean SEM. *p 0.05, **p 0.01, ***p 0.001, ****p 0.0001.
Figure 4. BDNF hydrogel implantation significantly improved functional diaphragm innervation following cervical contusion SCI. A, Following supramaximal phrenic nerve stimulation, we
obtained CMAP recordings from ipsilateral and contralateral hemidiaphragm for both blank hydrogel (left traces) and BDNF hydrogel (right traces) groups. Representative traces are from 3 weeks
postinjury. B, We quantified CMAP amplitudes at different time points postinjury. We expressed results as the mean SEM. **p 0.01, ***p 0.001.
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at 5weeks postcontusion,we found that BDNFhydrogel (Fig. 5B)
did not reduce lesion size compared with blank hydrogel control
(Fig. 5A) at all rostral–caudal distances from the lesion epicenter
(Fig. 5C; p  0.05 at all distances, ANOVA; n  5/group). Fur-
thermore, BDNF hydrogel did not reduce overall lesion volume
compared with blank hydrogel-implanted animals, as deter-
minedwith the Cavalieri estimator of volume (blank, 5.93 0.23
mm3; BDNF, 5.11 0.34mm3;F(3,16) 44.42, Tukey’s post-test;
p  0.54, ANOVA; n  5 rats/group; Figure 5D). We also mea-
sured lesion size in the contralateral hemicord; we found little-
to-no tissue damage in both groups, as well as no effect of BDNF
on lesion volume compared with blank gel (blank, 0.65  0.64
mm3; BDNF, 0.66 0.37 mm3, ANOVA; n 5 rats/group). In
these same cresyl violet-stained sections from the cervical spinal
cord, we found that BDNF hydrogel (Fig. 6B) also did not atten-
uate loss of ventral horn motor neurons located ipsilateral to the
contusion compared with blank hydrogel control (Fig. 6A) at 5
weeks post-SCI. Specifically, we observed no effect of BDNF hy-
drogel onmotor neuron counts that included allmotor neuron
populations (not just PhMNs), both at defined rostral–caudal
distances from the lesion epicenter (p  0.05 at all distances,
ANOVA; n  5/group; Fig. 6C) and across the entire cervical
enlargement (blank gel, 4382  289 motor neurons/animal;
BDNF, 4603  362 motor neurons/animal; F(3,16)  10.22,
Tukey’s post-test; p 0.90, ANOVA; n 5 rats/group; Fig. 6D).
BDNF also had no effects on motor neuron counts on the con-
tralateral side (blank gel, 9724  827 motor neurons/animal;
BDNF, 10,406  788 motor neurons/animal; F(3,16)  10.22,
Tukey’s post-test; p  0.22, ANOVA; n  5 rats/group). To-
gether, these histological findings suggest that the therapeutic
mechanism of action of BDNF hydrogel was not central neuro-
protection within the injured cervical spinal cord.
BDNF hydrogel significantly enhanced PhMN innervation of
the diaphragm
Though BDNF hydrogel did not reduce secondary degenera-
tion within the cervical spinal cord as assessed by lesion size
and motor neuron somal counts, BDNF may have instead
acted in a protective manner to maintain peripheral innerva-
tion at the diaphragm NMJ, the synapse that is critical for
PhMN–diaphragm connectivity. To address this possibility,
we selectively labeled PhMN cell bodies by intrapleurally injecting
the retrograde axonal tracer, Alexa Fluor 647-conjugated CTB, into
the ipsilateral hemidiaphragm. Importantly, we performed these
CTB injections at 4 weeks postinjury/treatment to assess muscle
innervation, because (1) PhMN soma will only be labeled with
CTB following intrapleural injection if NMJ innervation is intact
and (2) secondary PhMN loss is complete by this late injection
time point (Nicaise et al., 2013). In sagittal sections of the spinal
cord, CTB labeled a relatively compact column of PhMNs that
extended from C3 to C5 (Fig. 7A,B). In transverse sections, we
found CTB-labeled cells in the ipsilateral ventral horn at levels
C3-C5 (Fig. 7C). Compared with uninjured rats (252.7  13.38
PhMNs), both blank hydrogel-implanted (61.67 8.82 PhMNs)
and BDNF hydrogel-implanted (156.7  20.28 PhMNs) contu-
sion animals showed reduced numbers of retrogradely labeled
PhMNs (F(2,6) 40.96, Tukey’s post-test; intact vs blank gel, p
0.004; intact vs BDNF, p  0.0093; ANOVA; n  3 rats/group).
However, there were significantly greater numbers of CTB-
labeled PhMNs in the C3-C5 spinal cord of BDNF hydrogel ani-
mals compared with blank hydrogel controls (F(2,6)  40.96,
Tukey’s post-test; p  0.0097, ANOVA; Fig. 7D). Given the ab-
sence of motor neuron soma protection, these data suggest that
BDNF hydrogel robustly preserved diaphragm innervation by
PhMNs.
Figure 5. BDNF hydrogel did not decrease lesion size or lesion volume following cervical contusion SCI. A–C, In cresyl violet-stained transverse sections of the cervical spinal cord at 5 weeks
postcontusion, we found that BDNF hydrogel (B) did not reduce lesion size comparedwith blank hydrogel (A) at all rostral– caudal distances from the lesion epicenter (C).D, BDNF hydrogel did not
reduce overall lesion volume comparedwith blank hydrogel, as determinedwith the Cavalieri estimator of volume, in the hemicord both ipsilateral and contralateral to the contusion. Scale bar, 500
m.We expressed results as the mean SEM.
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These findings show that BDNF delivered locally to the cervi-
cal spinal cord can exert important therapeutic effects on PhMNs
spared the injury independent of overt somal protection. Along
these lines, BDNF hydrogel implantation also significantly re-
duced cell body atrophy ofCTB-labeled PhMNs (intact, 678.27
27.84 m2; blank gel, 496.47  27.74 m2; BDNF, 680.60 
23.78m2; F(2,111) 15.84, Tukey’s post-test; intact vs blank gel,
p 0.0001; blank gel vs BDNF, p 0.0001; intact vs BDNF, p
0.9; ANOVA; n  38 neurons/group; Fig. 7E), suggesting that
BDNFmay be able to improve the health of PhMNs after cervical
SCI.
To more definitively assess the effects of BDNF hydrogel on
diaphragm NMJ innervation, we performed detailed confocal
morphological analysis of individual NMJ phenotypes in the
Figure 6. BDNF hydrogel did not decrease cervical motor neuron cell body degeneration following cervical contusion SCI. A, B, In cresyl violet-stained sections from the cervical spinal cord, we
found thatBDNFhydrogel (B) didnot attenuate the loss of ventral hornmotor neurons located ipsilateral to the contusion comparedwithblankhydrogel (A) at 5weekspost-SCI (representative large
motor neurons indicated by arrows). C, D, We observed no effect of BDNF hydrogel on total motor neuron counts, both at defined rostral– caudal distances from the lesion epicenter (C) and across
the entire cervical enlargement in the hemicord both ipsilateral and contralateral to the contusion (D). We expressed results as the mean SEM. Scale bar, 200m.
Figure7. BDNFhydrogel increased counts of PhMNs retrogradely labeled from the diaphragm following cervical contusion SCI.We selectively labeled PhMN cell bodies by intrapleurally injecting
the retrograde tracer Alexa Fluor 647-conjugated CTB into ipsilateral hemidiaphragm.A,B, In sagittal spinal cord sections, CTB labeled a relatively compact column of PhMNs that extended from C3
to C5. C, In transverse sections, we found CTB-labeled cells in ipsilateral ventral horn at levels C3–C5.D, There were significantly greater numbers of CTB-labeled PhMNs in the C3–C5 spinal cord of
BDNF hydrogel animals comparedwith the blank hydrogel control. E, Somal size of CTB-labeled PhMNs in the BDNF hydrogel groupwas significantly greater than the blank hydrogel controls. Scale
bars: A, 500m; B, 100m; C, 50m.We expressed results as the mean SEM. *p 0.05, **p 0.01, ****p 0.0001.
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hemidiaphragm ipsilateral to the contusion, including separately
at dorsal, medial, and ventral subregions (Wright and Son, 2007;
Wright et al., 2007, 2009). At 5 weeks postcontusion, we performed
whole-mount immunohistochemistry onhemidiaphragmby label-
ing phrenic motor axons all the way to their terminals with neu-
rofilament (SMI-312) and synaptic vesicle protein 2 (SV2)
antibodies. We also labeled postsynaptic nicotinic acetylcholine
receptors in the muscle with Alexa Fluor 555-conjugated
-bungarotoxin. Compared with blank hydrogel (Fig. 8A),
BDNFhydrogel (Fig. 8B) significantly increased the percentage of
fully innervated NMJs in the dorsal and medial subregions of the
hemidiaphragm (dorsal: blank  25.4  7.01%; BDNF 
70.65  9.6%; p  0.0003; medial: blank  70.47  4.83%;
BDNF  86.95  3.92%; p  0.035; ventral: blank  95.57 
2.42%; BDNF 97.17 1.23%;F(5,18) 22.05, Tukey’s post-test
ANOVA; n 4 rats/group; Fig. 8C). In addition, compared with
blank hydrogel, BDNF decreased the percentage of both partially
denervated NMJs (dorsal: blank  47.65  4.83%; BDNF 
24.17  7.04%; p  0.0058; medial: blank  23.27  3.4%;
BDNF 9.77 1.93%; p 0.02; ventral: blank 3.57 2.03%,
BDNF  2.82  1.34%; F(5,18)  18.75, Tukey’s post-test,
ANOVA; n  4 rats/group; Fig. 8D) and completely denervated
NMJs (dorsal: blank 26.9 3.18%; BDNF 5.2 3.22%; p
0.0001; medial: blank 6.25 2.05%; BDNF 3.27 2.35%;
p 0.93; ventral: blank 0.90 0.54%; BDNF 0.50 0.28%;
F(5,18) 19.21; Tukey’s post-test, ANOVA; n 4 rats/group; Fig.
8E). In agreement with the EMG recordings (Fig. 3C), we ob-
served little diaphragm denervation in the ventral subregion of
the muscle, while the most significant denervation occurred in
the dorsal subregion and a smaller but still significant amount of
denervation was noted in the medial subregion (Fig. 8C–E). Just
as with the preservation of EMG amplitudes seen in the dorsal
subregion, BDNF hydrogel implantation robustly enhanced
NMJ innervation at the dorsal subregion, but also exerted a
more modest therapeutic effect on innervation at the medial
subregion. We previously showed that the contralateral hemi-
diaphragm is not significantly affected in this unilateral cervi-
cal contusion model (Nicaise et al., 2012); therefore, we have
Figure 8. BDNF hydrogel preserved morphological innervation of the diaphragm by phrenic motor neurons following cervical contusion SCI. At 5 weeks postcontusion, we performed whole-
mount immunohistochemistry on hemidiaphragm by labeling phrenic motor axons all the way to their terminals with neurofilament (SMI-312) and SV2 antibodies. We also labeled postsynaptic
nicotinic acetylcholine receptors in themusclewith Alexa Fluor 555-conjugated-bungarotoxin.A–E, Comparedwith blank hydrogel (A), BDNF hydrogel (B) significantly increased the percentage
of fully innervated NMJs (C), as well as decreased the percentage of both partially denervated (D) and completely denervated (E) NMJs. C–E, BDNF hydrogel implantation robustly preserved NMJ
innervation at the dorsal subregion, but also exerted a more modest therapeutic effect on innervation at the medial subregion. We characterized individual NMJs as follows: intact (I.); fully
denervated (F.D.); partially denervated (P.D.). Scale bar, 50m.We expressed results as the mean SEM. *p 0.05.
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not conducted this analysis of contralateral muscle again in
the current study.
Collectively, these findings with retrograde labeling and NMJ
morphology analysis (along with CMAPs) demonstrate for the
first time that BDNF significantly enhanced diaphragm NMJ in-
nervation by PhMNs after SCI.
BDNF hydrogel implantation following cervical contusion
enhanced serotonergic innervation of PhMNs
BDNF may have also exerted therapeutic effects on respiratory
neural circuitry via mechanisms in addition to enhanced NMJ
innervation. Descending serotonergic input plays an important
role in regulating the excitability of spinal cordmotor neurons, in
particular their response to glutamatergic signaling (Perrier et al.,
2013). It has been reported that BDNF-expressing mesenchymal
stem cells significantly increased 5-HT fiber growth after SCI
(Sasaki et al., 2009). Therefore, in the context of diaphragm func-
tion, BDNF may be able to strengthen rhythmic excitatory input
to PhMNs from spared and/or regrowing rVRGaxons by increas-
ing serotonergic innervation of PhMNs via 5-HT fiber sprouting.
To address this possibility, we quantified 5-HT immunostaining
in the C3-C5 ventral horn ipsilateral to the contusion at 5 weeks
postcontusion. Compared with blank hydrogel control (Fig.
9A,C), we found that BDNF hydrogel (Fig. 9B,D) enhanced the
density of serotonergic axons directly surrounding CTB-labeled
PhMNs.
We extended this analysis of 5-HT fiber growth within the
PhMN pool by performing quantification of (1) numbers of
5-HT axon profiles, (2) length of these 5-HT axon profiles,
and (3) integrated intensity of 5-HT immunostaining at multiple
defined distances from CTB-labeled PhMNs in transverse sec-
tions (Fig. 9E,F). We present each of these datasets at three sep-
arate distances from PhMNs to show the proximity effects of
BDNFhydrogel on 5-HT axonal growth responseswith respect to
the location of PhMNs. Compared with blank hydrogel control,
BDNF increased the number of 5-HT axonal profiles at all three
distances (F(5,30)  27.55, Tukey’s post-test; 0–50 m: blank 
49.83  5.84; BDNF  100  7.35; p  0.04; 50–100 m:
blank 111.6 6.0; BDNF 162.50 7.61; p 0.03; 100–150
m: blank  135.83  10.68; BDNF  223.33  21.55; p 
0.0001, ANOVA; n 3 rats/group; Fig. 9G). BDNF also increased
total 5-HT axonal length at all three distances (F(5,30) 76.80,
Tukey’s post-test; 0–50 m: blank  272.72  20.01 m;
BDNF  712.17  37.91; p  0.0001; 50–100 m: blank 
776.47 63.94; BDNF 1253.12 34.54; p 0.0001; 100–150
m: blank  901.11  40.24; BDNF  1565.89  84.01; p 
0.0001, ANOVA; n 3 rats/group; Fig. 9H). In addition, BDNF
increased integrated intensity of 5-HT immunostaining com-
pared with blank hydrogel (F(5,30)  78.08, Tukey’s post-test;
0–50 m: blank  0.74  0.08 a.u.; BDNF  1.91  0.10 a.u.;
p 0.04; 50–100m: blank 3.49 0.14 a.u.; BDNF 4.88
0.29 a.u.; p  0.009; 100–150 m: blank  5.16  0.23 a.u.;
BDNF 7.14 0.49 a.u.; p 0.0001, ANOVA; n 3 rats/group;
Fig. 9I).
Last, we conducted quantitative analysis of synaptic input to
PhMNs by serotonergic axons using multilabeling immunohis-
tochemistry for 5-HT axons, CTB postsynaptic PhMNs, and
the presynaptic marker synaptophysin. We assessed the number
of putative synaptic connections between 5-HT fibers and CTB-
labeled PhMNs using confocal acquisition of z-stacks and quan-
tification of 5-HT axon–PhMN contacts using single-z section
analysis to establish direct apposition of presynaptic 5-HT/syn-
aptophysin axon terminals and postsynaptic CTB PhMNs.
Compared with blank hydrogel control (Fig. 10A) and BDNF
hydrogel (Fig. 10B) animals showed significantly more putative
synaptic contacts between 5-HT axons and PhMNs (blank gel,
1.6 0.29/PhMN soma; BDNF, 5.2 0.35; t 7.86, df 28; p
0.0001, unpaired t test; n 4 rats/group; Fig. 10C).
Collectively, these results show that BDNF hydrogel promoted
plasticity of axonal populations associated with enhanced PhMN
excitability. This represents an additionalmechanismpotentially re-
sponsible for functional recovery, particularly the increased EMG
amplitudes that may be associated with rhythmic drive to PhMNs
from supraspinal respiratory centers.
Discussion
Novel biomaterial-based strategy for SCI repair
As a viable drug delivery system for BDNF therapeutics, we have
developed a hydrogel loaded with BDNF. All of the materials
used in this delivery platform are biocompatible natural poly-
saccharides that have been shown to be safe for human use
(Komai et al., 2005; Scarano et al., 2009; Neimert-Andersson
et al., 2014). The BDNF-loaded hydrogel can be implanted
subdurally for local BDNF delivery at the injury site without
damaging spinal cord tissue. Clinically, the hydrogel could be
implanted, for example, when spine decompression/stabiliza-
tion surgery is performed so that no additional surgery will be
required for hydrogel administration.
Our innovative approach is significant for developing a ther-
apy for respiratory dysfunction after SCI because we are harness-
ing the power of biomaterial design to address both biological
considerations (i.e., the delivery of specific therapeutic factors to
target relevant pathogenic mechanisms) and practical issues (i.e.,
local delivery to the injury site with appropriate dosing and du-
ration).We found that BDNF exerted effects on peripheralmech-
anisms such as enhancedNMJ innervation and central reparative
processes such as stimulating 5-HT axonal growth.
OurBDNFhydrogel releases relatively high amounts of BDNF
in the first 2 d, followed by low-dose release (364.2–29.5 ng/d) for
17 d. While the formulation we assessed was functionally and
histopathologically efficacious, the optimal dose and duration of
BDNF treatment for cervical SCI remain unknown. Further-
more, persistently high levels of BDNFwithin the spinal cord can
result in unwanted side effects such as neuropathic pain, hyper-
reflexia, and abnormal motor function (Boyce and Mendell,
2014). Therefore, it will be important in future work to test ad-
ditional release profiles to identify the most effective treatment
paradigm with minimized side effects.
Local delivery of BDNF hydrogel is a clinically viable
approach for reducing secondary damage to respiratory
circuitry following SCI
Despite a body of work showing the neuroprotective effects of
BDNF after axotomy, in SCImodels, and in degenerative diseases
such as ALS (Weishaupt et al., 2012), our data do not show pro-
tective effects on cervical motor neuron survival or lesion size.
Instead, our results shed light on an incredibly important outcome
of secondary injury thathasnot receivedextensive attention:periph-
eral muscle denervation by the axon terminals of motor neurons
spared by the injury. Even though the cell bodies of these neurons
persist, the circuit is incomplete. BDNFsignaling throughTrkBnor-
mally acts tomaintain diaphragmNMJ structure and PhMN inner-
vation in intact/non-SCI conditions (Mantilla et al., 2014b;Greising
et al., 2015); BDNFhydrogel delivery inourmodelmay represent an
extension of this important function in the injured setting. These
datawithBDNFhydrogel implantationdemonstrate the therapeutic
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Figure9. BDNFhydrogel implantation following cervical contusion enhanced serotonergic innervationof PhMNs.Wequantified 5-HT immunostaining in the C3–C5ventral horn ipsilateral to the
contusion at 5 weeks postinjury. A–D, Compared with blank hydrogel control (A, C), BDNF hydrogel (B, D) enhanced the density of serotonergic axons surrounding CTB-labeled PhMNs at 5 weeks
postcontusion. E–I, Compared with blank hydrogel control (E), BDNF (F ) increased the number of 5-HT axonal profiles (G), total 5-HT axonal length (H ), and integrated intensity of 5-HT
immunostaining (I ) atmultiple defined distances from CTB-labeled PhMNs. Scale bars:A,B, E, F, 50m; C,D, 100m.We expressed results as themean SEM. *p 0.05, **p 0.01, ***p
0.001, ****p 0.0001.
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power of addressing muscle denervation that underlies persistent
diaphragm paralysis.
Our NMJ morphology data are only from a single late time
point, raising the possibility that, instead of acting via initial pres-
ervation of NMJ innervation, BDNF hydrogel promoted NMJ
reinnervation following initial denervation (or a combination of
both). It is challenging to distinguish between an NMJ that was
never denervated and one that was denervated and subsequently
reinnervated as reinnervatedNMJs often appearmorphologically
normal by this late time point postinsult. However, we observed
CMAP preservation starting at the relatively early time of 2 weeks
post-SCI, supporting the contention that BDNF hydrogel was
acting to prevent initial denervation at diaphragmNMJ. Further-
more, we did not observe any hallmarks of peripheral plasticity at
the NMJ with BDNF hydrogel such as terminal sprouting, nodal
sprouting, or regrowth of initially retracted phrenicmotor axons,
though we also performed this assessment at a late time point
long after BDNF stopped being released from the hydrogel. On
the other hand, although the effects of BDNF hydrogel on 5-HT
axonal growth around the CTB-labeled PhMNs could be due to
initial preservation instead of sprouting, we observed increased
5-HT fiber density with BDNF hydrogel rostral to the contusion
at locations where secondary degeneration is not significant, sug-
gesting that BDNF is promoting the growth of these axons and
not sparing.
BDNF hydrogel may also be acting via various
reparative mechanisms
Given the clinical relevance of delayed intervention in the SCI
patient population, it will be important in future work to test
hydrogel implantation at time points beyond the window of early
secondary degeneration. Reparative effects of interventions such
as BDNF delivery may be viable targets in this context, including
the sprouting of sparedmotor axons and reinnervation of dener-
vated endplates that is a potentially powerful substrate for pro-
moting functional recovery. To this point,NMJ reinnervation is a
mechanism by which functional recovery can occur after motor
neuron injury, including spontaneously without therapeutic in-
terventions. In our cervical contusionmodel, we previously dem-
onstrated that partial loss of the PhMN pool is followed by
sprouting and reinnervation of a portion of the denervated junc-
tions, which was associated with progressive, spontaneous recov-
ery of diaphragm function as assessed by CMAP amplitudes
(though recovery was only minimal; Nicaise et al., 2013). BDNF
hydrogel implantationmay enhance this process ofNMJ reinner-
vation. In addition to our data demonstrating morphological
effects at the NMJ, previous work has also shown that BDNF can
induce other changes at the diaphragmNMJ. For example, BDNF
enhances synaptic transmission at the diaphragmNMJ (Mantilla
et al., 2004), including in the C2 hemisection model using intra-
pleural adeno-associated virus–BDNF injection (Gransee et al.,
2013), suggesting additional peripheral mechanisms relevant to
diaphragm recovery.
Other reparative mechanisms may also be influenced by
BDNF delivered locally to the injured cervical spinal cord. For
example, BDNF hydrogel may be capable of modulating PhMN
properties such as intrinsic excitability and response to bulbospi-
nal input (Gill et al., 2016). This strengthened synaptic input to
PhMNs could be from the small number of ipsilateral rVRG ax-
ons spared by contusion and/or latent contralateral rVRG input
that is mostly inactive before injury. BDNF can increase the ex-
citability of spinal cord motor neurons involved in the control of
limb function (Boyce et al., 2012; Boyce andMendell, 2014). The
relatively small amount of spontaneous diaphragm recovery that
occurs after C2 hemisection SCI is mediated in part by BDNF
acting upon TrkB receptors expressed by PhMNs (Mantilla et al.,
2013, 2014a). Diaphragm activation by PhMNs can also be en-
hanced in C2 hemisection with intrathecal BDNF injection
(Mantilla et al., 2013), intraspinal transplantation of mesenchy-
mal stem cells engineered to overexpress BDNF (Gransee et al.,
2015), and selective overexpression of TrkB in PhMNs (Gransee
et al., 2013; Martínez-Ga´lvez et al., 2016). Using phrenic nerve
recordings as a measure of PhMN output, BDNF has also been
shown to play a key role in the plasticity of spared glutamatergic
input to PhMNs that underlies the partial recovery of diaphragm
function observed after cervical hemisection (Dale-Nagle et al.,
2010). Given this body of work, it will be important moving
forward to test the effects of our BDNF hydrogel on PhMN excit-
ability, particularly at the single-cell level and in response to bul-
bospinal synaptic input.
We found that BDNF hydrogel did not improve EMG ampli-
tude in the ventral andmedial subregions of the hemidiaphragm,
but only in the dorsal portion of themuscle.We hypothesize that
the beneficial effect of BDNF hydrogel on EMG burst amplitudes
in the dorsal hemidiaphragm may be due to the location of hy-
drogel implantation. Based on previous work from both our lab-
oratory and others, it has been shown that different subregions of
the hemidiaphragm are innervated by phrenic motor neurons
located at different locations within the C3–C5 spinal cord (Li et
al., 2015). In general, PhMNs whose soma are found at C3 pri-
marily innervate the ventral portion of the muscle. PhMNs at the
opposite end of the PhMN pool (C5) primarily innervate the
Figure10. BDNFhydrogel implantation increased5-HT/synaptophysinpresynaptic terminals at CTBPhMNsoma.Weassessed thenumber of putative synaptic connections between5-HT
fibers and CTB-labeled PhMNs using confocal acquisition of z-stacks and quantification of 5-HT axon-PhMN contacts using single-z section analysis to establish the direct apposition of presynaptic
5-HT/synaptophysin axon terminals and postsynaptic CTB PhMNs. A–C, Compared with blank hydrogel control (A), BDNF hydrogel (B) animals showed significantly more putative synaptic
contacts between 5-HT axons and PhMNs (C). We expressed results as the mean SEM. Scale bar, 10m. ****p 0.0001.
Ghosh, Wang et al. • BDNF Preserves Diaphragm Function after SCI J. Neurosci., June 27, 2018 • 38(26):5982–5995 • 5993
dorsal hemidiaphragm subregion, while those at C4 primarily
innervate themedial part of themuscle. Our unilateral contusion
injury is located at the C4/C5 level, which explains why the EMG
burst amplitudes in blank-hydrogel control animals are lowest at
the dorsal and medial subregions (particularly the dorsal subre-
gion). We implanted the BDNF hydrogel (as well as the control
blank hydrogel) directly above the contusion epicenter; there-
fore, we hypothesize that the local delivery of BDNF exerted ef-
fects close to the hydrogel implantation site, which may explain
the selective effects in the dorsal hemidiaphragm.
BDNF hydrogel promoted serotonergic axon growth
BDNF acting throughTrkB plays an important role in neuroplas-
ticity following SCI, including the regeneration of axotomized
neurons and the sprouting of spared fibers (Weishaupt et al.,
2012). A number of previous studies has shown that BDNF treat-
ment in SCI models increases the survival of neurons and axonal
growth when delivered by intrathecal infusion (Bregman et al.,
1997; Ye and Houle, 1997; Novikova et al., 2000, 2002), intraspi-
nal viral transduction (Koda et al., 2004; Boyce et al., 2012), and
stem/progenitor cell transplantation (Lu et al., 2005; Lynskey et
al., 2006). Along these lines, we observed robustly increased
PhMN innervation by 5-HT axons in response to BDNF hydro-
gel, presumably via an axonal growth response (and not via spar-
ing, as discussed above). BDNF hydrogel may have also restored
diaphragm function in our cervical contusionmodel by promot-
ing the regrowth of injured bulbospinal rVRG axons and synaptic
reconnection with spared PhMNs. Furthermore, the generation
of novel connections (that differ from the original preinjury cir-
cuitry) by growing axons can promote some degree of functional
recovery post-SCI, either spontaneously (Bareyre et al., 2004) or
in response to themanipulation of axonal growth inhibitors (Sie-
gel et al., 2015). Accordingly, BDNF hydrogel may have resulted
in reinnervation of PhMNs by sprouting contralateral rVRG ax-
ons spared by the injury. Supporting these possibilities, bulbos-
pinal axon populations have repeatedly shown axon growth
responses to BDNF (Weishaupt et al., 2012).
Conclusions
Our findings may have profound implications for SCI patients
with persistent diaphragm dysfunction. We have developed a
novel and safe biomaterial-based platform to locally deliver
BDNF to the injured cervical spinal cord with controlled dosing
and duration. Furthermore, in a clinically relevant animal model
of cervical contusion SCI, we have successfully demonstrated the
therapeutic efficacy of this promising drug delivery system for
effectively repairing PhMN–diaphragm circuitry and maintain-
ing diaphragmatic respiratory function. In addition, we demon-
strate novel mechanisms by which local BDNF delivery to an SCI
site can repair respiratory neural circuitry simultaneously atmul-
tiple neuroanatomical locations: enhanced diaphragm innerva-
tion peripherally at theNMJ and increased PhMN innervation by
descending 5-HT axons centrally within the ventral horn of the
cervical spinal cord.
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